Effects of Quinapril and Losartan on Insulin Sensitivity in Genetic Hypertensive Rats with Different Metabolic Abnormalities
Authors:
- Mitsuko DaiharaMDMitsuko Daihara
- Hiroki TamakawaHTHiroki Tamakawa
- Taeko NozueTNTaeko Nozue
- Kiminori KawaharaKKKiminori Kawahara
- 1 July 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 34 (1) , 28-33
Abstract
This study was designed to investigate the effects of the angiotensin-converting enzyme (ACE) inhibitor quinapril and the angiotensin II-receptor antagonist losartan on insulin sensitivity in two types of genetic hypertensive rats with insulin resistance. Quinapril (3 mg/kg) and losartan (10 mg/kg) decreased the systolic blood pressure to almost the same extent in both spontaneously hypertensive rats (SHRs) and Dahl salt-sensitive (Dahl S) rats. Quinapril increased the glucose requirement for the euglycemic clamp test in both SHRs and Dahl S rats, whereas losartan increased it in SHRs but not in Dahl S rats. The severity of the metabolic abnormalities may be responsible for the failure of losartan to improve the insulin sensitivity in Dahl S rats because serum insulin, total cholesterol, triglyceride, and free fatty acids (FFAs) were higher in the Dahl S rats than in SHRs. A kinin antagonist, Hoe 140, inhibited the increase in the glucose requirement by quinapril without affecting the depressor effect of quinapril in SHRs. In conclusion, quinapril improved the insulin sensitivity more effectively than did losartan in the genetic hypertensive rats with insulin resistance and relatively severe metabolic abnormalities. Based on our findings, one of the mechanisms underlying the difference between quinapril and losartan may thus be endogenous kinins.Keywords
This publication has 27 references indexed in Scilit:
- Blockade of angiotensin converting enzyme but not of angiotensin AT1 receptors improves glucose toleranceEuropean Journal of Pharmacology, 1997
- Effects of Angiotensin Receptor Antagonist and Angiotensin Converting Enzyme Inhibitor on Insulin Sensitivity in Fructose-Fed Hypertensive Rats and Essential HypertensivesAmerican Journal of Hypertension, 1995
- Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor.Hypertension, 1994
- Hyperinsulinemia, sex, and risk of atherosclerotic cardiovascular disease.Circulation, 1991
- Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular DiseaseDiabetes Care, 1991
- Insulin Resistance, Hyperinsulinemia, Hypertriglyceridemia, and Hypertension: Parallels Between Human Disease and Rodent ModelsDiabetes Care, 1991
- A Comparison of the Effects of Hydrochlorothiazide and Captopril on Glucose and Lipid Metabolism in Patients with HypertensionNew England Journal of Medicine, 1989
- The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertensionArchives of internal medicine (1960), 1989
- Banting lecture 1988. Role of insulin resistance in human diseaseDiabetes, 1988
- Insulin Resistance in Essential HypertensionNew England Journal of Medicine, 1987